Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2022
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma
Camila Guerrero, Noemi Puig, Maria-Teresa Cedena, et al.
Blood Cancer Discovery
|
April 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Juan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 14, 2023
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
Michael A Thompson, Mario Boccadoro, Xavier Leleu, et al.
Blood
|
February 7, 2015
The cellular origin and malignant transformation of Waldenström macroglobulinemia
Bruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
American Journal of Hematology
|
November 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy
Aintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
Bruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Hemasphere
|
June 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing
Natalia Buenache, Marta Lasa, Andrés Arroyo, et al.
Blood
|
May 22, 2025
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment
Marta Lasa, Carmen Gonzalez, Laura Notarfranchi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 10, 2022
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
Luis-Esteban Tamariz-Amador, Paula Rodríguez-Otero, Ana Jiménez-Ubieto, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2022
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma
Camila Guerrero, Noemi Puig, Maria-Teresa Cedena, et al.
Blood Cancer Discovery
|
April 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Juan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 14, 2023
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
Michael A Thompson, Mario Boccadoro, Xavier Leleu, et al.
Blood
|
February 7, 2015
The cellular origin and malignant transformation of Waldenström macroglobulinemia
Bruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
American Journal of Hematology
|
November 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy
Aintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
Bruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Hemasphere
|
June 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing
Natalia Buenache, Marta Lasa, Andrés Arroyo, et al.
Blood
|
May 22, 2025
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment
Marta Lasa, Carmen Gonzalez, Laura Notarfranchi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 10, 2022
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
Luis-Esteban Tamariz-Amador, Paula Rodríguez-Otero, Ana Jiménez-Ubieto, et al.
Page
of 9